About Cynapsus Therapeutics
Cynapsus Therapeutics is a company based in Toronto (Canada) founded in 2004 was acquired by Sunovion in August 2016.. Cynapsus Therapeutics has raised $25.06 million across 6 funding rounds from investors including Orbimed, Sunovion and Aisling Capital. Cynapsus Therapeutics offers products and services including APL-130277.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cynapsus Therapeutics Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cynapsus Therapeutics
Cynapsus Therapeutics offers a comprehensive portfolio of products and services, including APL-130277. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sublingual thin film for on-demand management of Parkinson's OFF episodes.
Funding Insights of Cynapsus Therapeutics
Cynapsus Therapeutics has successfully raised a total of $25.06M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.75 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $16.8M
-
First Round
First Round
(29 Sep 2011)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Post-IPO - Cynapsus Therapeutics | Valuation |
investors |
|
| Jul, 2014 | Amount | Grant - Cynapsus Therapeutics | Valuation |
investors |
|
| Apr, 2014 | Amount | Series B - Cynapsus Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cynapsus Therapeutics
Cynapsus Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Sunovion and Aisling Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cynapsus Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cynapsus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cynapsus Therapeutics Comparisons
Competitors of Cynapsus Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cynapsus Therapeutics
When was Cynapsus Therapeutics founded?
Cynapsus Therapeutics was founded in 2004 and raised its 1st funding round 7 years after it was founded.
Where is Cynapsus Therapeutics located?
Cynapsus Therapeutics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Cynapsus Therapeutics a funded company?
Cynapsus Therapeutics is a funded company, having raised a total of $25.06M across 6 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Sep 29, 2011.
What does Cynapsus Therapeutics do?
Cynapsus Therapeutics was founded in 2004 in Toronto, Canada, within the biotechnology sector. Focus is placed on developing a sublingual thin film formulation of apomorphine hydrochloride, known as APL-130277, for managing OFF episodes in advanced Parkinsons disease patients. A Phase 2 clinical trial for this product candidate has been successfully completed. Operations center on CNS disorder treatments, with apomorphine currently approved only as a subcutaneous injection in the United States.
What products or services does Cynapsus Therapeutics offer?
Cynapsus Therapeutics offers APL-130277.
Who are Cynapsus Therapeutics's investors?
Cynapsus Therapeutics has 4 investors. Key investors include Orbimed, Sunovion, Aisling Capital, and Venrock.